Dr. von Moltke brings over 30 years of deep drug development experience and a proven track record of clinical and regulatory success at both ...

Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, today announced the submission of a Premarket Approval ...

MRO Corp. (MRO), the leader in clinical data exchange, announces a transformative extension of its interoperability solutions ...

The Stand Up for Science rally in Seattle, part of a nationwide effort, filled the mural amphitheater at the Seattle Center. ...

A new search tool unveiled Friday increases public access to information about the connections between advisors to the ...

Resmed (NYSE: RMD) announced today that it began a comprehensive brand evolution to unify its brand portfolio.

ResMed has launched a rebrand to unify its portfolio and reflect its increasing direct-to-consumer engagement.

Medical school mission statements are becoming increasingly laden with diversity, equity and inclusion (DEI) and social ...

From cancer research to architecture to engineering, this week we featured women who led their respective fields to recognize Women's History Month.

Bioventus' full-year 2024 worldwide revenue totaled $573.3 million, an increase of 11.9% compared to the prior year. On an organic* basis, revenue increased 14.4%, driven by double-digit growth in ...

"The Nu.Q® Cancer test could support physicians with clinical decision-making following LDCT by identifying the patients at highest risk and whose nodules are more likely to be cancerous, while ...

Endo achieved 2024 revenues and adjusted EBITDA expectations, while progressing the Company's strategic prioritiesXIAFLEX® hit record revenues of $516 million in 2024, up 9% versus 2023The Company ...